RNAC
Price
$11.90
Change
-$0.31 (-2.54%)
Updated
Apr 29, 04:59 PM (EDT)
Capitalization
316.33M
SNPX
Price
$2.43
Change
-$0.01 (-0.41%)
Updated
Apr 29, 04:59 PM (EDT)
Capitalization
3.39M
Ad is loading...

RNAC vs SNPX

Header iconRNAC vs SNPX Comparison
Open Charts RNAC vs SNPXBanner chart's image
Cartesian Therapeutics
Price$11.90
Change-$0.31 (-2.54%)
Volume$600
Capitalization316.33M
Synaptogenix
Price$2.43
Change-$0.01 (-0.41%)
VolumeN/A
Capitalization3.39M
RNAC vs SNPX Comparison Chart
Loading...
RNAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RNAC vs. SNPX commentary
Apr 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNAC is a Hold and SNPX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 29, 2025
Stock price -- (RNAC: $12.21 vs. SNPX: $2.44)
Brand notoriety: RNAC and SNPX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RNAC: 41% vs. SNPX: 70%
Market capitalization -- RNAC: $316.33M vs. SNPX: $3.39M
RNAC [@Biotechnology] is valued at $316.33M. SNPX’s [@Biotechnology] market capitalization is $3.39M. The market cap for tickers in the [@Biotechnology] industry ranges from $279.46B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RNAC’s FA Score shows that 0 FA rating(s) are green whileSNPX’s FA Score has 2 green FA rating(s).

  • RNAC’s FA Score: 0 green, 5 red.
  • SNPX’s FA Score: 2 green, 3 red.
According to our system of comparison, SNPX is a better buy in the long-term than RNAC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RNAC’s TA Score shows that 5 TA indicator(s) are bullish.

  • RNAC’s TA Score: 5 bullish, 3 bearish.

Price Growth

RNAC (@Biotechnology) experienced а +18.09% price change this week, while SNPX (@Biotechnology) price change was +19.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.09%. For the same industry, the average monthly price growth was -2.03%, and the average quarterly price growth was -10.94%.

Reported Earning Dates

RNAC is expected to report earnings on Mar 13, 2025.

SNPX is expected to report earnings on Mar 27, 2025.

Industries' Descriptions

@Biotechnology (+4.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RNAC($316M) has a higher market cap than SNPX($3.39M). SNPX YTD gains are higher at: -29.686 vs. RNAC (-31.826). SNPX has higher annual earnings (EBITDA): -6.76M vs. RNAC (-75.99M). RNAC has more cash in the bank: 213M vs. SNPX (22.1M). RNAC has higher revenues than SNPX: RNAC (38.9M) vs SNPX (0).
RNACSNPXRNAC / SNPX
Capitalization316M3.39M9,319%
EBITDA-75.99M-6.76M1,124%
Gain YTD-31.826-29.686107%
P/E RatioN/A2.75-
Revenue38.9M0-
Total Cash213M22.1M964%
Total Debt14MN/A-
FUNDAMENTALS RATINGS
RNAC: Fundamental Ratings
RNAC
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
92
P/E GROWTH RATING
1..100
34
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RNAC
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 6 days ago
82%
Declines
ODDS (%)
Bearish Trend 9 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
RNAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X94978.7500001223.914100
+1.31%
Bitcoin cryptocurrency
GME27.590.13
+0.47%
GameStop Corp
AAPL210.140.86
+0.41%
Apple
TSLA285.880.93
+0.33%
Tesla
SPY550.850.21
+0.04%
SPDR® S&P 500® ETF

RNAC and

Correlation & Price change

A.I.dvisor indicates that over the last year, RNAC has been closely correlated with WINT. These tickers have moved in lockstep 94% of the time. This A.I.-generated data suggests there is a high statistical probability that if RNAC jumps, then WINT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNAC
1D Price
Change %
RNAC100%
+3.21%
WINT - RNAC
94%
Closely correlated
-5.79%
NCNA - RNAC
92%
Closely correlated
+1.82%
CDTX - RNAC
92%
Closely correlated
-2.37%
NBY - RNAC
91%
Closely correlated
+0.86%
SNPX - RNAC
91%
Closely correlated
+4.94%
More

SNPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNPX has been closely correlated with CDTX. These tickers have moved in lockstep 93% of the time. This A.I.-generated data suggests there is a high statistical probability that if SNPX jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNPX
1D Price
Change %
SNPX100%
+4.94%
CDTX - SNPX
93%
Closely correlated
-2.37%
WINT - SNPX
92%
Closely correlated
-5.79%
NCNA - SNPX
92%
Closely correlated
+1.82%
NBY - SNPX
91%
Closely correlated
+0.86%
RNAC - SNPX
91%
Closely correlated
+3.21%
More